Who is sponsoring NCT04603339?

NCT04603339 is sponsored by University of Dublin, Trinity College.

What drugs are being tested in NCT04603339?

Interventions in NCT04603339: Multidisciplinary rehabilitation programme delivered via telehealth.

What condition does NCT04603339 study?

NCT04603339 studies Oesophageal Cancer, Gastric Cancer.

Is NCT04603339 still recruiting?

NCT04603339 is currently completed. Last updated 13 April 2022.

Last reviewed 2022-04-13 · How we verify

NCT04603339: ReStOre@Home

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

ReStOre@Home: Feasibility Study of a 12-week Multidisciplinary Telehealth Rehabilitation Programme for Survivors of Upper Gastrointestinal (UGI) Cancer

Completed NA Last updated 13 April 2022

What this trial tests

NA trial testing Multidisciplinary rehabilitation programme delivered via telehealth in Oesophageal Cancer in 12 participants. Completed in 1 January 2022.

Timeline

1 May 2021

Primary endpoint
30 October 2021

1 January 2022

Quick facts

Lead sponsor	University of Dublin, Trinity College
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	12
Start date	1 May 2021
Primary completion	30 October 2021
Estimated completion	1 January 2022
Sites	1 location across Ireland

Drugs / interventions tested

Multidisciplinary rehabilitation programme delivered via telehealth

Conditions studied

Oesophageal Cancer — all drugs for Oesophageal Cancer →
Gastric Cancer — all drugs for Gastric Cancer →

Sponsor

University of Dublin, Trinity College

Who can join

Adults 18 to 100, any sex, with Oesophageal Cancer or Gastric Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Feasibility study of a 12-week multidisciplinary telehealth rehabilitation programme for survivors of upper gastrointestinal (UGI) cancer

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Telehealth Delivery of a Multi-Disciplinary Rehabilitation Programme for Upper Gastro-Intestinal Cancer: ReStOre@Home Feasibility Study.
Brennan L, Sadeghi F, O'Neill L, Guinan E, et al · · 2022 · cited 20× · PMID 35681687 · DOI 10.3390/cancers14112707
ReStOre@Home: Feasibility study of a virtually delivered 12-week multidisciplinary rehabilitation programme for survivors of upper gastrointestinal (UGI) cancer - study protocol.
O'Neill L, Guinan E, Brennan L, Brennan L, et al · · 2020 · cited 5× · PMID 34046552 · DOI 10.12688/hrbopenres.13185.2
ReStOre@Home: Feasibility study of a virtually delivered 12-week multidisciplinary rehabilitation programme for survivors of upper gastrointestinal (UGI) cancer - study protocol
O'Neill L, Guinan E, Brennan L, Doyle SL, et al · · 2021 · DOI 10.12688/hrbopenres.13185.2

Verify or expand the search:

Other recruiting trials for Oesophageal Cancer

Currently open trials in the same condition.

NCT06906887 — PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer · Phase 2 · recruiting
NCT06422403 — A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers · Phase 2 · recruiting
NCT06364553 — Esophageal Self-expandable Metal Stent for Malignant Strictures: a Safety and Efficacy Study · NA · recruiting
NCT06440174 — Understanding the Variation of Modern Endoscopic Ultrasound Use in Patients with Oesophageal Cancer (VALUE) · recruiting
NCT06212700 — PRIORITY-CONNECT 2 Pilot Trial · NA · recruiting

Other University of Dublin, Trinity College trials

Trials by the same sponsor.

NCT07581093 — The REACT Study: REhabilitation and ACTivity in Allogenic Transplant · not yet recruiting
NCT07393880 — Bimodal Electrical-Sound Stimulation and Auditory Training for Chronic Tonal Tinnitus · NA · recruiting
NCT07196020 — Prediction of Venous Thrombosis During chemotherapy-the PINPOINT Study · not yet recruiting
NCT06280885 — A Flexible Individualized ExeRcise Programme for Cancer Patients During ChEmotherapy · NA · recruiting
NCT06820008 — Measurement and Impact of Physical Impairment in Amyotrophic Lateral Sclerosis: Use of Digital Technologies - A Precisio · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04603339 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Dublin, Trinity College
Last refreshed: 13 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04603339.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing